Iris Roth - Feb 13, 2023 Form 3 Insider Report for Zentalis Pharmaceuticals, Inc. (ZNTL)

Signature
/s/ Andrea Paul, attorney-in-fact for Iris Roth
Stock symbol
ZNTL
Transactions as of
Feb 13, 2023
Transactions value $
$0
Form type
3
Date filed
2/13/2023, 06:07 AM
Next filing
Mar 2, 2023

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney